NCT02612207View on ClinicalTrials.gov

Point-of-Care System for Determination of Bilirubin Capacity in Neonates

CompletedOBSERVATIONAL
Enrollment

161

Participants

Timeline

Start Date

August 1, 2015

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Jaundice, NeonatalHyperbilirubinemiaBilirubin-Induced Neurological Dysfunction (BIND)
Interventions
DEVICE

Bilirubin Binding Capacity by Hematofluorometry Validation

Observation study

Trial Locations (2)

94305

Lucile-Packard Children's Hospital at Stanford, Stanford

08701

AVIV Biomedical, Inc., Lakewood

Sponsors

Collaborators (1)

Aviv Biomedical, Inc.
All Listed Sponsors
collaborator

Aviv Biomedical, Inc.

UNKNOWN

lead

Stanford University

OTHER

NCT02612207 - Point-of-Care System for Determination of Bilirubin Capacity in Neonates | Biotech Hunter | Biotech Hunter